Seizing the opportunity
PSA national president Fei Sim talks about the importance of transforming pharmacy education to match evolving clinical roles We have spoken ad nauseam about how the aging population, increased healthcare …
Don’t let Christmas cheer cost you dear
Entertainment expenses – what you need to know in the lead up to Christmas Christmas is right around the corner, and for those who know me well, it’s no secret …
November MIMS update
Some of the recent changes to the medicines landscape, with new products, presentations, indications and contraindications New Products Elafibranor (Iqirvo) and its main active metabolite GFT1007 are peroxisome proliferator-activated receptor …
Financial considerations to prepare your pharmacy for sale
The process of selling a pharmacy can be complex and typically requires a team effort involving owners, brokers, lawyers, accountants, bookkeepers, and other stakeholders, writes Peak Strategies’ Patricia Aditopo Proper …
October MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Capivasertib (Truqap) is an inhibitor of the kinase activity of all 3 isoforms …
Can trusts still hold shares?
Understanding the new pharmacy ownership rules in Queensland with Lachlan Ballinger, Yield Advisory The Queensland Government has introduced the most significant changes to pharmacy ownership rules in over 20 years. …
Why paying for expertise is an investment – not a cost
Business brokers, finance experts and legal advisors all provide critical support for pharmacy owners, writes AP Group national sales executive, Chris Swifte When it comes to selling a major asset, …
Flexing: a tool for pharmacy teams navigating personality differences
In a pharmacy where pressure is high and teamwork essential, personality differences are inevitable. But conflict doesn’t have to be, writes pharmacist Chantelle Turner. Speaking with a client recently, they …
Australia’s most reported medicines
PDL reveals its top 10 most reported medicines over the last financial year—and the recurring themes in incidents Each year, PDL reviews data reported by members, and reflects on the …
Building strong relationships in business: tips for success
Throughout my years in business and in life, I have always believed that relationships are the cornerstone of success, writes AP Group national sales executive, Chris Swifte Whether working with …
September MIMS update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products • Albutrepenonacog alfa (Idelvion) is a recombinant fusion protein linking recombinant coagulation factor …
The power of succession planning and empowering leaders
Succession planning is one of the most important considerations for pharmacy owners, writes AP Group’s Western Australia state manager, Chris Swifte Beyond simply maintaining day-to-day operations, it’s about securing the …